Biohit - Innovating for Health

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
Financial calendar
Thu 02/25/2016 9:30 A.M.   Financial Statement release 2015
Wed 03/30/2016   The date by which a shareholder can notify the company’s board of directors of an issue that he or she requests to be addressed at the general meeting
Mon 04/25/2016 3 P.M   Annual General Meeting
Thu 08/18/2016 9:30 A.M.   Interim Report Q2 Jan-June 2016 
Major shareholders -  02/28/2017
 
 
Holdings, total
Holdings, %
1
Suovaniemi Osmo Antero
Holdings, total
3,230,567
Holdings, %
21.98
2
Interlab Oy
Holdings, total
2,034,497
Holdings, %
13.84
3
Suovaniemi Ville Roi
Holdings, total
579,580
Holdings, %
3.94
4
Joel Suovaniemi
Holdings, total
541,280
Holdings, %
3.68
5
Suovaniemi Oili
Holdings, total
400,535
Holdings, %
2.72
6
Genetic Analysis As
Holdings, total
350,000
Holdings, %
2.38
7
Härkönen Matti
Holdings, total
325,165
Holdings, %
2.21
8
Suovaniemi Vesa Jukka Markku
Holdings, total
262,619
Holdings, %
1.79
9
Oy Etra Invest Ab
Holdings, total
200,000
Holdings, %
1.36
10
Luostarinen Reijo
Holdings, total
100,000
Holdings, %
0.68

Contact

Biohit group 
Mr Semi Korpela, CEO
     
Headquarters    
Visiting address : Laippatie 1, 00880 Helsinki, Finland
Tel (switchboard) : +358 9 773 861
Email : info@biohit.fi
An Investis Flife service. © 2017
Investis